Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$555M |
| 2 |
Citigroup
C
|
+$407M |
| 3 |
Medtronic
MDT
|
+$401M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$392M |
| 5 |
Gilead Sciences
GILD
|
+$362M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.43B |
| 2 |
Amazon
AMZN
|
+$1.32B |
| 3 |
Apple
AAPL
|
+$1.1B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$995M |
| 5 |
Bank of America
BAC
|
+$726M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 83.47% |
| 2 | Technology | 3.02% |
| 3 | Healthcare | 2.92% |
| 4 | Consumer Discretionary | 2.17% |
| 5 | Financials | 2.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
11926
CALL
Petrobras Class A
PBR.A
$139B
| $46.2K | ﹤0.01% |
3,500
+3,100
| +775% | +$42K |
2022 Q1
10 quarters
|
|
|
EVAX
11927
Evaxion A/S
EVAX
$28.5M
| $46.1K | ﹤0.01% |
+2,965
| New | +$44.7K |
2024 Q3
0 quarters
|
|
11928
PUT
Fathom Holdings
FTHM
$7.64M
| $46.1K | ﹤0.01% |
17,800
+17,600
| +8,800% | +$41.1K |
2023 Q3
4 quarters
|
|
|
CLSD
11929
PUT
DELISTED
Clearside Biomedical
CLSD
| $46.1K | ﹤0.01% |
2,420
+2,413
| +34,471% | +$41.2K |
2022 Q4
7 quarters
|
|
11930
PUT
Ducommun
DCO
$2.65B
| $46.1K | ﹤0.01% |
700
-2,000
| -74% | -$125K |
2022 Q4
7 quarters
|
|
|
RMAX
11931
PUT
DELISTED
RE/MAX Holdings
RMAX
| $46.1K | ﹤0.01% |
3,700
-18,500
| -83% | -$191K |
2023 Q3
4 quarters
|
|
11932
CALL
YieldMax MSFT Option Income Strategy ETF
MSFO
$88.2M
| $46K | ﹤0.01% |
+2,300
| New | +$46.8K |
2024 Q3
0 quarters
|
|
11933
Minerva Neurosciences
NERV
$164M
| $46K | ﹤0.01% |
+17,239
| New | +$50.1K |
2024 Q3
0 quarters
|
|
|
PINC
11934
PUT
DELISTED
Premier
PINC
| $46K | ﹤0.01% |
2,300
+2,200
| +2,200% | +$43.7K |
2022 Q4
7 quarters
|
|
11935
PUT
Suzano
SUZ
$10.3B
| $46K | ﹤0.01% |
4,600
+4,000
| +667% | +$39.1K |
2023 Q4
3 quarters
|
|
11936
PUT
iShares Emerging Markets Dividend ETF
DVYE
$1.22B
| $45.9K | ﹤0.01% |
+1,600
| New | +$43.7K |
2024 Q3
0 quarters
|
|
|
MRC
11937
PUT
DELISTED
MRC Global
MRC
| $45.9K | ﹤0.01% |
3,600
-600
| -14% | -$7.76K |
2023 Q1
6 quarters
|
|
|
RGLS
11938
CALL
DELISTED
Regulus Therapeutics
RGLS
| $45.8K | ﹤0.01% |
29,200
+12,200
| +72% | +$20.2K |
2022 Q3
8 quarters
|
|
11939
PUT
YieldMax META Option Income Strategy ETF
FBY
$120M
| $45.8K | ﹤0.01% |
2,300
+100
| +5% | +$1.87K |
2024 Q2
1 quarter
|
|
|
ARBK
11940
Argo Blockchain
ARBK
$31.8M
| $45.8K | ﹤0.01% |
+175
| New | +$48.1K |
2024 Q3
0 quarters
|
|
|
LUXH
11941
DELISTED
LuxUrban Hotels Inc. Common Stock
LUXH
| $45.8K | ﹤0.01% |
+7,777
| New | +$62.8K |
2024 Q3
0 quarters
|
|
11942
CALL
The Honest Company
HNST
$540M
| $45.7K | ﹤0.01% |
12,800
+3,200
| +33% | +$12K |
2021 Q2
13 quarters
|
|
11943
CALL
Full House Resorts
FLL
$49.8M
| $45.7K | ﹤0.01% |
9,100
+6,200
| +214% | +$31.6K |
2021 Q4
11 quarters
|
|
11944
CALL
Purple Innovation
PRPL
$9.42M
| $45.7K | ﹤0.01% |
1,848
+472
| +34% | +$13.6K |
2020 Q2
17 quarters
|
|
11945
Provident Financial Services
PFS
$2.91B
| $45.5K | ﹤0.01% |
2,453
-144,943
| -98% | -$2.56M |
2023 Q1
6 quarters
|
|
|
MTLS
11946
PUT
Materialise
MTLS
$493M
| $45.5K | ﹤0.01% |
8,300
-900
| -10% | -$4.81K |
2020 Q4
15 quarters
|
|
11947
PUT
Methode Electronics
MEI
$538M
| $45.4K | ﹤0.01% |
3,800
-6,200
| -62% | -$69.2K |
2022 Q4
7 quarters
|
|
11948
PUT
OneWater Marine
ONEW
$162M
| $45.4K | ﹤0.01% |
1,900
-36,600
| -95% | -$899K |
2022 Q4
7 quarters
|
|
11949
Lithia Motors
LAD
$6.43B
| $45.4K | ﹤0.01% |
143
-24,798
| -99% | -$6.91M |
2018 Q3
24 quarters
|
|
11950
PUT
ProShares UltraShort Real Estate
SRS
$17.3M
| $45.4K | ﹤0.01% |
1,025
-925
| -47% | -$47.2K |
2022 Q4
7 quarters
|
|
Similar funds
Citadel Advisors's Q3 2024 Portfolio in Review
As of Q3 2024, Citadel Advisors held 15,731 positions worth $518B, up 4.9% from $494B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Citadel Advisors's Q3 2024 filing shows 1,612 new, 6,434 increased, 5,866 reduced and 1,610 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M. The largest sale was Invesco QQQ Trust, an estimated $1.43B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, up from 82% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q3 2024 buy was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M.
- Citadel Advisors added most to NVIDIA in Q3 2024, an estimated $555M increase.
- Citadel Advisors's biggest Q3 2024 reduction was Invesco QQQ Trust, cutting an estimated $1.43B.
- Citadel Advisors fully exited Domino's in Q3 2024, selling an estimated $186M.
- Citadel Advisors's ten largest holdings make up 30% of its $518B portfolio in Q3 2024.
- Citadel Advisors opened 1,612 new positions and closed 1,610 in Q3 2024.
- Citadel Advisors's portfolio value rose 4.9% quarter-over-quarter to $518B.
Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.